These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26699604)

  • 21. Effectiveness of renal denervation in the treatment of hypertension: a literature review.
    Shah RT; Wang BX
    Clin Hypertens; 2022 Apr; 28(1):11. PubMed ID: 35422052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal Denervation in the treatment of Resistant Hypertension.
    Yap LB; Balachandran K
    Med J Malaysia; 2021 Nov; 76(6):893-897. PubMed ID: 34806679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Denervation: Where to Now?
    Wimmer NJ; Mauri L
    Curr Cardiol Rep; 2015 Dec; 17(12):116. PubMed ID: 26482759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New opportunities of renal denervation].
    Agaeva RA; Danilov NM; Shelkova GV; Matchin YG; Chazova IE
    Ter Arkh; 2020 Jul; 92(6):84-88. PubMed ID: 33346499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
    Kario K; Mahfoud F; Kandzari DE; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Brar S; Hettrick DA; Fahy M; Böhm M
    Hypertens Res; 2023 Jan; 46(1):280-288. PubMed ID: 36241705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M; Mahfoud F; Townsend RR; Kandzari DE; Pocock S; Ukena C; Weber MA; Hoshide S; Patel M; Tyson CC; Weil J; Agdirlioglu T; Fahy M; Kario K
    Eur Heart J; 2019 Mar; 40(9):743-751. PubMed ID: 30608521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
    Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial.
    Ormiston JA; Watson T; van Pelt N; Stewart R; Stewart JT; White JM; Doughty RN; Stewart F; Macdonald R; Webster MW
    EuroIntervention; 2013 May; 9(1):70-4. PubMed ID: 23685297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal arteries denervation with second generation systems: a remedy for resistant hypertension?
    Versaci F; Sciarretta S; Scappaticci M; Calcagno S; di Pietro R; Sbandi F; Dei Giudici A; Del Prete A; de Angelis S; Biondi-Zoccai G
    Eur Heart J Suppl; 2020 Nov; 22(Suppl L):L160-L165. PubMed ID: 33239993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan　- Safety and Efficacy of Renal Denervation at 3 Years.
    Kario K; Yamamoto E; Tomita H; Okura T; Saito S; Ueno T; Yasuhara D; Shimada K;
    Circ J; 2019 Feb; 83(3):622-629. PubMed ID: 30760655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal Denervation After the SPYRAL HTN-OFF MED Trial: Putting a Complex Study Into Context.
    Schlaich MP; Esler MD
    Hypertension; 2017 Dec; 70(6):1076-1079. PubMed ID: 29038200
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
    Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal sympathetic denervation for treatment of hypertension: where are we now in 2019?
    Dasgupta I; Sharp ASP
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):498-506. PubMed ID: 31268917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.
    Kandzari DE; Bhatt DL; Sobotka PA; O'Neill WW; Esler M; Flack JM; Katzen BT; Leon MB; Massaro JM; Negoita M; Oparil S; Rocha-Singh K; Straley C; Townsend RR; Bakris G
    Clin Cardiol; 2012 Sep; 35(9):528-35. PubMed ID: 22573363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal Denervation: Is It Ready for Prime Time?
    Lauder L; Wolf MA; Scholz SS; Hohl M; Mahfoud F; Böhm M
    Curr Cardiol Rep; 2019 Jul; 21(8):80. PubMed ID: 31278490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal denervation - can we press the "ON" button again?
    Kądziela J; Warchoł-Celińska E; Prejbisz A; Januszewicz A; Witkowski A; Tsioufis K
    Postepy Kardiol Interwencyjnej; 2018; 14(4):321-327. PubMed ID: 30603021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
    Esler MD; Böhm M; Sievert H; Rump CL; Schmieder RE; Krum H; Mahfoud F; Schlaich MP
    Eur Heart J; 2014 Jul; 35(26):1752-9. PubMed ID: 24898552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal denervation for resistant hypertension and beyond.
    Laffin LJ; Bakris GL
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.